Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR) [Phase 2]
Phase 2 trial results (EFFIKIR) evaluating an anti-KIR monoclonal antibody as maintenance therapy in adults with acute myeloid leukemia have…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) [Phase 1]
A Phase 1 trial evaluating Volasertib plus Decitabine in adults with acute myeloid leukemia has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine [Phase 1, Phase 2]
This trial update covers a Phase 1/Phase 2 study of laromustine combined with infusional cytarabine in elderly patients with acute myeloid l…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations [Phase 1]
Phase 1 trial evaluating pacritinib in combination with chemotherapy for adults with acute myeloid leukemia, including FLT3-mutant AML; the …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS [Phase 1]
Phase 1 clinical trial evaluating Yttrium-90 anti-CD45 monoclonal antibody BC8 followed by donor stem cell transplant in patients with high-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Red Cell Transfusion Goals in Patients With Acute Leukemias [Phase 1]
Phase 1 trial completed evaluating red blood cell transfusion goals in patients with acute leukemias (acute lymphoblastic leukemia, acute my…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Epigenetic Reprogramming in Relapse AML [Phase 1]
A Phase 1 trial evaluating epigenetic reprogramming for relapse acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating inducible regulatory T cells (iTregs) in non-myeloablative sibling donor peripheral blood stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial results update for Vyxeos (CPX-351) in relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes; results we…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating vadastuximab talirine administered before or after allogeneic stem cell transplant in acute myeloid leukemia; stu…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant [Phase 2]
Phase II multicenter trial evaluating CD26 inhibition with sitagliptin for engraftment after umbilical cord blood transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]
Phase 2 results from a study using donor umbilical cord blood stem cell transplants in patients with hematologic malignancies have been post…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating cytarabine and daunorubicin or idarubicin with or without vorinostat for younger patients with untreated acute myel…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
Phase 3 trial update for vadastuximab talirine combined with azacitidine or decitabine in older patients with newly diagnosed acute myeloid …
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML) [Phase 1, Phase 2]
Clinical trial update on panobinostat in combination with idarubicin and cytarabine in older adults with newly diagnosed acute myeloblastic …
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to Azacitidine or Decitabine After at Least 6 Courses or Relapsing After a Response [Phase 2]
Phase II trial evaluating SGI-110 in patients with various high-risk myelodysplastic syndromes and related conditions not responding to prio…
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy [Phase 1]
Phase 1 clinical trial evaluating a new anti-cancer immunotherapy in adults with acute myeloid leukemia who had suboptimal response to induc…
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Reduced Intensity Double Umbilical Cord Blood Transplantation [Phase 2]
Phase 2 results for reduced-intensity double umbilical cord blood transplantation were completed and results posted in 2018. The study evalu…
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS). [Phase 1, Phase 2]
Clinical trial update on safety of oral azacitidine (CC-486) as maintenance therapy after allogeneic stem cell transplantation in AML or MDS…
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update examining SGI-110 with donor lymphocyte infusions after allogeneic stem cell transplantation for myelodysplast…
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML [Phase 1]
A Phase 1 trial of metformin combined with cytarabine for relapsed/refractory acute myeloid leukemia was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating clofarabine plus cytarabine in previously untreated acute myeloid leukemia and high-risk myelodysplastic syndrome h…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS) [Phase 2, Phase 3]
A nonmyeloablative preparative regimen using Mylotarg (gemtuzumab ozogamicin) was studied in Phase 2/Phase 3 trials for high-risk acute myel…
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP) [Phase 1, Phase 2]
A clinical trial investigating sensitization of non-M3 acute myeloid leukemia blasts to all-trans retinoic acid using epigenetic treatment w…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS [Phase 2]
Phase 2 study evaluating multiple-dose, dose-escalation of AEB1102 in patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome has …